Medications with Generic Name Beginning ‘D’, Page 5

Page 5 of 417 « First Page « … 3 4 5 6 7 … 10 15 20 25 30 … » Last Page »

Dalfampridine

Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking…

Mylan Pharmaceuticals Inc.13 September 2022

DALFAMPRIDINE

Dalfampridine extended-release tablet is indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed…

Micro Labs Limited28 November 2022

AMPYRA (Dalfampridine)

AMPYRA is indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14). ]…

Acorda Therapeutics, Inc.23 January 2023

Dalfampridine

Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking…

Ascend Laboratories, LLC30 January 2023

Dalfampridine

Dalfampridine Extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking…

Accord Healthcare Inc.15 February 2023

Page 5 of 417 « First Page « … 3 4 5 6 7 … 10 15 20 25 30 … » Last Page »

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.